Effectiveness and safety of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in older adults with type 2 diabetes: A nationwide population‐based study

Diabetes Obesity and Metabolism ◽

10.1111/dom.14261 ◽

2020 ◽

Author(s):

Seung Jin Han ◽

Kyoung Hwa Ha ◽

Nami Lee ◽

Dae Jung Kim

Keyword(s):

Type 2 Diabetes ◽

Older Adults ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Population Based Study ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Outcomes for Inappropriate Renal Dose Adjustment of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus: Population-Based Study

Mayo Clinic Proceedings ◽

10.1016/j.mayocp.2019.06.010 ◽

2020 ◽

Vol 95 (1) ◽

pp. 101-112

Author(s):

Sangmo Hong ◽

Kyungdo Han ◽

Cheol-Young Park

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dose Adjustment ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Population Based Study ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A population-based cohort study

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2020.108546 ◽

2021 ◽

Vol 171 ◽

pp. 108546

Author(s):

Chen-Yi Wu ◽

Chun-Ying Wu ◽

Chung-Pin Li ◽

Yiing-Jenq Chou ◽

Yi-Hsian Lin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Bullous Pemphigoid ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase‐4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population‐based cohort study

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13955 ◽

2019 ◽

Vol 85 (8) ◽

pp. 1719-1727 ◽

Cited By ~ 12

Author(s):

Jong‐Mi Seong ◽

Jeong Yee ◽

Hye Sun Gwak

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cohort Study ◽

Autoimmune Disease ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study

BMJ ◽

10.1136/bmj.k872 ◽

2018 ◽

pp. k872 ◽

Cited By ~ 45

Author(s):

Devin Abrahami ◽

Antonios Douros ◽

Hui Yin ◽

Oriana Hoi Yun Yu ◽

Christel Renoux ◽

...

Keyword(s):

Type 2 Diabetes ◽

Inflammatory Bowel Disease ◽

Cohort Study ◽

Bowel Disease ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Inflammatory Bowel

Download Full-text

Dipeptidyl peptidase‐4 inhibitors and risk of diabetic retinopathy progression in patients with type 2 diabetes: a population‐based cohort study

Acta Ophthalmologica ◽

10.1111/aos.13972_74 ◽

2018 ◽

Vol 96 (S261) ◽

pp. 23-23

Keyword(s):

Type 2 Diabetes ◽

Diabetic Retinopathy ◽

Cohort Study ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Effectiveness and safety of dipeptidyl peptidase 4 inhibitors in the management of type 2 diabetes in older adults: a systematic review and development of recommendations to reduce inappropriate prescribing

BMC Geriatrics ◽

10.1186/s12877-017-0571-8 ◽

2017 ◽

Vol 17 (S1) ◽

Cited By ~ 12

Author(s):

Gisela Schott ◽

Yolanda V Martinez ◽

R. Erandie Ediriweera de Silva ◽

Anna Renom-Guiteras ◽

Anna Vögele ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Older Adults ◽

Inappropriate Prescribing ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study

Acta Diabetologica ◽

10.1007/s00592-020-01533-5 ◽

2020 ◽

Vol 57 (10) ◽

pp. 1181-1192

Author(s):

Yi-Chuan Chen ◽

Tien-Hsing Chen ◽

Chi-Chin Sun ◽

Jau-Yuan Chen ◽

Shy-Shin Chang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cohort Study ◽

Autoimmune Diseases ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-205216 ◽

2014 ◽

Vol 74 (11) ◽

pp. 1968-1975 ◽

Cited By ~ 43

Author(s):

Seoyoung C Kim ◽

Sebastian Schneeweiss ◽

Robert J Glynn ◽

Michael Doherty ◽

Allison B Goldfine ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Autoimmune Diseases ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

2209-PUB: Factors Associated with Switching from Sulfonylureas (SUs) to Dipeptidyl Peptidase-4 Inhibitors (DPP-4i) among Individuals with Type 2 Diabetes in the United States

Diabetes ◽

10.2337/db20-2209-pub ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 2209-PUB

Author(s):

XI TAN ◽

LINGFENG YANG ◽

KAMLESH KHUNTI ◽

RUYA ZHANG ◽

DIANA ZHANG ◽

...

Keyword(s):

United States ◽

Type 2 Diabetes ◽

The United States ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Factors Associated ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Mechanisms of Neurodegeration in Type 2 Diabetes and the Neuroprotective Potential of Dipeptidyl Peptidase 4 Inhibitors

Current Medicinal Chemistry ◽

10.2174/0929867322666150227153308 ◽

2015 ◽

Vol 22 (13) ◽

pp. 1573-1581 ◽

Cited By ~ 21

Author(s):

E. Matteucci ◽

O. Giampietro

Keyword(s):

Type 2 Diabetes ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text